Quick Answer
Turn Therapeutics Inc. reported Net Income of -$3.19 million for fiscal year 2025.
Turn Therapeutics Inc. — Key Financials by Year
| Metric | 2025 | 2024 | 2023 |
|---|---|---|---|
| Net Income | -$3.19M -80.6% |
-$1.77M | — |
| Diluted EPS | -$0.12 -71.4% |
-$0.07 | — |
| Total Assets | $12.16M +493.6% |
$2.05M | — |
| Stockholders Equity | $4.69M +2741.4% |
-$177.4K -306.9% |
$85.8K |
| R&D Expense | $265.6K +8.0% |
$246.0K | — |
| Operating Income | -$5.86M -226.0% |
-$1.80M | — |
Most Recent Quarter
| Metric | Quarter Ending | Value | YoY | QoQ |
|---|---|---|---|---|
| Net Income | September 30, 2025 | -$1.90M | -185.7% | -185.7% |
| Diluted EPS | September 30, 2025 | -$0.07 | -133.3% | -133.3% |
| Total Assets | September 30, 2025 | $4.30M | — | +109.8% |
| Stockholders Equity | September 30, 2025 | $504.0K | +221.7% | +384.1% |
| R&D Expense | September 30, 2025 | $158.7K | +3.5% | +3.5% |
| Operating Income | September 30, 2025 | -$1.91M | -184.3% | -184.3% |
- Turn Therapeutics Inc. reported Net Income of -$3.19 million for fiscal year 2025.
- Turn Therapeutics Inc. showed a decrease of -80.6% in Net Income compared to the prior fiscal year.
- Turn Therapeutics Inc. reported Diluted EPS of $0.12 per share (loss) for fiscal year 2025.
- Turn Therapeutics Inc. showed a decrease of -71.4% in Diluted EPS compared to the prior fiscal year.
- Turn Therapeutics Inc. reported Total Assets of $12.16 million for fiscal year 2025.
- Turn Therapeutics Inc. showed an increase of +493.6% in Total Assets compared to the prior fiscal year.
- Turn Therapeutics Inc. reported Stockholders Equity of $4.69 million for fiscal year 2025.
- Turn Therapeutics Inc. showed an increase of +2741.4% in Stockholders Equity compared to the prior fiscal year.
- Turn Therapeutics Inc. reported R&D Expense of $265.6 thousand for fiscal year 2025.
- Turn Therapeutics Inc. showed an increase of +8.0% in R&D Expense compared to the prior fiscal year.
- Turn Therapeutics Inc. reported Operating Income of -$5.86 million for fiscal year 2025.
- Turn Therapeutics Inc. showed a decrease of -226.0% in Operating Income compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: